Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cataract device safety tracked over 20 months in extension study

NCT ID NCT07246915

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Edinburgh Biosciences Ltd Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 61 people who previously used the REVISYON SDS 100 device for mild-to-moderate cataract. Researchers will check for side effects and measure vision changes over about 20 months. No new treatment is given; the goal is to see if the device stays safe and works well long-term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
REVISYON SDS 100 medical device
What this could lead to
If successful, this study could confirm that the device remains safe and effective over the long term for treating mild-to-moderate cataract.
What could go wrong
This is an observational extension study with no new treatment, so it cannot prove the device works better than other options. Results depend on data from a prior study and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

blindness (disorder) cataract senile cataract vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGE-RELATED CATARACT CATARACT MILD CATARACT MODERATE CATARACT VISION LOSS

Contacts and locations

Locations

  • Dr. Berghian Ophthalmology Clinic

    Timișoara, Romania

  • Institutul Clinic de Urgențe Oftalmologice Prof. Dr. Mircea Olteanu

    Bucharest, Romania

  • Opticlass Clinic

    Timișoara, Romania

  • Romania Clinica Vista, Ophtalmology Department

    Timișoara, Romania

  • Spitalul Clinic CF Timisoara, Ophthalmology Department

    Timișoara, Romania

  • Vedis Ophthalmology Clinic | Ophthalmological Center Dr. Samoila

    Cluj-Napoca, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.